Research reveals varicose veins treatment industry to be worth $475 million by 2024

9th August 2016 by Daryll Baker0
Picture14.jpg

Varicose veins can cause more than physical pain and discomfort. Their unsightly appearance can also be a source of much emotional pain and anxiety for many people. However, there are many treatments available now for people who suffer from the condition.

According to the National Institute of Health, 60% of all women and men suffer from a vein disorder of some description. Due to poor circulation and blood pooling into the legs, many people who live with the condition complain of their veins throbbing, especially at night time. It can also cause a painful rash or ulcer.

There are many causes of varicose veins, it is not just a result of advancing years. Other contributory factors include can be caused due to an unhealthy lifestyle habits, obesity, poor blood pressure levels, sleep disorders and genetic disorders.

The physical and emotional pain that is caused by varicose veins means that more and more people are seeking help to cure the problem. According to a report by Grand View Research, the global varicose vein treatment market is expected to reach 475 million US dollars by 2024. Ever improving technology and people requiring less-invasive treatments are said to be the reasons for the surge in the market.

The report discovers that due to its cost and time efficiency, the most profitable procedure in 2015 was sclerotherapy. The other benefits of the treatment such as the reduced amount of scarring involved, the fact that the procedure is painless are all key factors that contribute to this.

The minimal side effects of the Closurefast technique in the endovenous ablation treatment sector is said to be the reason why it is the fastest growing segment in the industry.

The most widely used medical procedure in 2015 was endevonuos chemoablation. This is said to be due to the less invasive nature of the procedure.

North America held the largest market share of varicose vein treatments in 2016. This is reported to be due to the increasing rate of varicose and spider vein incidence within the population and people requiring treatment for aesthetic purposes.

In Europe, a high growth rate in less-invasive procedures for is forecast, as of 2016. This is said to be due to advanced treatment procedures and favourable initiatives brought in by government.

Pacific Asia is forecast to have the fastest growth in varicose veins treatments. This is due to many factors such as rising disposable income, improved healthcare infrastructure and increased patient awareness about the benefits of early treatment for varicose veins.


Leave a Reply

Your email address will not be published. Required fields are marked *


vas_logo

Daryll Baker is a Consultant Vascular Surgeon at the Royal Free Hospital London and Clinical Lead for North Central Region Vascular Services.

He read Medicine at Oxford University and trained in Vascular Surgery in Nottingham, London and Edinburgh. He obtained his research PhD from the University of Wales.

Contact

Wellington Hospital
34 Circus Road
London
NW8 9SG

020 7722 7370

Copyright 2016 The Vascular Consultancy